Loading stock analysis…
Evidence Synthesis
Last synthesized: 18 Sept 2026, 00:39
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Here is the rewritten text in a standard shift narrative format, using only past and present tense facts from the JSON: The daily volume of EXPLEOSOL has decelerated to 35973 shares, down from 171205 shares.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 35.38 % | 13.2 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 13.2 % | 12.08 | ▲ |
| REVENUE_GROWTH_YOY | 12.3 % | 67.3 | ▼ |
| PRICE_CHANGE_PERCENT | 2.069 % | — | - |
| DAILY_VOLUME | 35,973 shares | 1,71,205 | ▼ |
| CLOSE_PRICE | 898.05 INR | 879.85 | ▲ |
| NEWS_SENTIMENT_SCORE | 1 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 0 count | 1 | ▼ |
| TARGET_PRICE_PREMIUM | 26.94 % | — | - |